REGN
REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC. (REGN) has 3 SEC Form 4 filings (26 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 7, 2026.
The most active filer is Director RYAN ARTHUR F with 3 filings. Insiders have net sold $278K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Leonard S. Schleifer
- Employees:15,158
- HQ:Tarrytown, NY, US
- IPO:1991-04-02
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$278K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 200 | $130K | Jul 7 | SEC ↗ | |
| Director | Sale | 100 | $71K | May 4 | SEC ↗ | |
RYAN ARTHUR FFirst filing | Director | Sale | 100 | $78K | Feb 11 | SEC ↗ |
Congress trading REGN
See timeline →- RSen. Alan ArmstrongPurchase$1,001 - $15,0002026-03-27
- DRep. Gilbert CisnerosSale$1,001 - $15,0002026-05-15
- DRep. Ro KhannaPurchase$1,001 - $15,0002026-04-13
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
REGENERON PHARMACEUTICALS, INC. is in the Healthcare sector.